Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04834102
Status:
UNKNOWN
Last Update Posted:
2021-04-06
First Post:
2021-04-04
Brief Title:
COVID-19 Induced Telogen Effluvium
Sponsor:
Istanbul Medeniyet University
Organization:
Istanbul Medeniyet University
Study Overview
Official Title:
COVID-19 Induced Telogen Effluvium
Status:
UNKNOWN
Status Verified Date:
2021-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection
Detailed Description:
Telogen effluvium TE is one of the most common causes of non-scarring alopecia During the COVİD-19 pandemic there is an increased number of Telogen effluvium patientsThis study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None